R. Nicholson

🏛️ Revolving Door

Former Government Position:

Secretary Dept of Veterans Affairs; Ambassador to Holy See Dept of State

Share:𝕏LinkedInFacebook
🤖

AI Overview

R. Nicholson has appeared in 361 federal lobbying filings at Brownstein Hyatt Farber Schreck, LLP, representing 50 clients. As a former government official, they bring insider expertise to their lobbying work — part of Washington's "revolving door." Active across 24 policy areas.

361
Total Filings
1
Firms
50
Clients
24
Issue Areas

Issue Areas

HOUTRAFUEVETNATFINFORGOVLAWHCRURBMMMMEDTAXPHAEDUAVITORSCIINDRESBUDENGDEF

Filing History

YearFilingsClients
2018339
20192710
20205620
20215919
20226720
20234414
20243412
20254113

Firms

Brownstein Hyatt Farber Schreck, LLP361 filings

Top Clients

Chrysalis Holdings, INC. (D.B.A. Newday)31 filings
Bruno Independent Living Aids, INC.29 filings
Kuwait & Gulf Link Holding28 filings
Beep, INC.27 filings
Caredx, INC.23 filings
Walgreen Co.16 filings
Virtu Financial, INC.10 filings
Colorado Springs10 filings
Weconnect Health Management9 filings
Alaw9 filings
Dar Al Handasah Consultants Shair & Partners Holdings LTD9 filings
Crowell & Moring LLP Obo Cogitativo, INC.7 filings
Tribal Solutions Medical7 filings
Total Community Options, INC. D/B/A Innovage7 filings
University of Phoenix7 filings
Medivant Healthcare7 filings
Wellhive7 filings
Kabafusion6 filings
Crowell & Moring LLP Obo Victims of State Sponsored Terrorism6 filings
The Northeast Maglev, LLC5 filings

Related Analysis

🏛️ Revolving Door Premium
Do ex-government lobbyists earn more?
🕸️ Network Analysis
Explore connections between firms and lobbyists
🎯 Market Concentration
How concentrated is the lobbying market?

Related Investigations

The Revolving Door Exposed
How former government officials become the most powerful lobbyists.
Follow the Money
Tracking lobbying dollars through the financial system.
Foreign Governments Are Lobbying Congress
1,000+ foreign entities from 50+ countries lobby the US government.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.

Explore More

← All Lobbyists🏛️ Revolving Door🕸️ Network Analysis🏛️ Agency Pressure 🔍 Investigations

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.